Medtronic’s RAFT Keeps Hopes Afloat For Shift To CRT In Milder Heart Failure

Data reported last week could hasten moves by electrophysiologists to implant price-premium cardiac resynchronization therapy systems rather than conventional defibrillators in patients with earlier stage heart failure.